Processa Pharmaceuticals, Inc. (PCSA) stock
PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.86+0.02 (+1.09%)
Close on Nov 13, 2026Market cap $5.20MP/E –Yield –
Processa Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
Processa Pharmaceuticals's total assets was $182.01M at Sep 30, 2026. For fiscal 2025 it was $7.81M, up 142.0% from the year before. Over ten years it grew 54.0% a year on average. The highest annual figure on record is $26.46M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.81M | +142.0% |
| FY2024 | Dec 31, 2024 | $3.23M | -44.2% |
| FY2023 | Dec 31, 2023 | $5.79M | -32.9% |
| FY2022 | Dec 31, 2022 | $8.62M | -67.4% |
| FY2021 | Dec 31, 2021 | $26.46M | +5.0% |
| FY2020 | Dec 31, 2020 | $25.21M | +131.7% |
| FY2019 | Dec 31, 2019 | $10.88M | -12.8% |
| FY2018 | Dec 31, 2018 | $12.48M | +318.4% |
| FY2017 | Dec 31, 2017 | $2.98M | +26.1% |
| FY2016 | Dec 31, 2016 | $2.36M | +2167.0% |
| FY2015 | Dec 31, 2015 | $104.32K | -95.9% |
| FY2014 | Dec 31, 2014 | $2.55M | -13.3% |
| FY2013 | Dec 31, 2013 | $2.94M | -24.4% |
| FY2012 | Dec 31, 2012 | $3.88M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $182.01M | +2299.8% |
| Q2 FY2026 | Jun 30, 2026 | $2.07M | -57.0% |
| Q1 FY2026 | Mar 31, 2026 | $4.52M | +40.0% |
| Q4 FY2025 | Dec 31, 2025 | $7.81M | +58.1% |
| Q3 FY2025 | Sep 30, 2025 | $7.58M | -0.2% |
| Q1 FY2025 | Mar 31, 2025 | $4.81M | -51.6% |
| Q4 FY2024 | Dec 31, 2024 | $3.23M | -44.2% |
| Q3 FY2024 | Sep 30, 2024 | $4.94M | -38.9% |
| Q2 FY2024 | Jun 30, 2024 | $7.60M | -24.7% |
| Q1 FY2024 | Mar 31, 2024 | $9.94M | -20.0% |
| Q4 FY2023 | Dec 31, 2023 | $5.79M | -32.9% |
| Q3 FY2023 | Sep 30, 2023 | $8.08M | -56.6% |
| Q2 FY2023 | Jun 30, 2023 | $10.09M | -53.4% |
| Q1 FY2023 | Mar 31, 2023 | $12.43M | -48.8% |
| Q4 FY2022 | Dec 31, 2022 | $8.62M | -67.4% |
| Q3 FY2022 | Sep 30, 2022 | $18.60M | -35.9% |
| Q2 FY2022 | Jun 30, 2022 | $21.66M | -30.4% |
| Q1 FY2022 | Mar 31, 2022 | $24.30M | -27.1% |
| Q4 FY2021 | Dec 31, 2021 | $26.46M | +5.0% |
| Q3 FY2021 | Sep 30, 2021 | $29.03M | +202.7% |
| Q2 FY2021 | Jun 30, 2021 | $31.14M | +211.0% |
| Q1 FY2021 | Mar 31, 2021 | $33.34M | +233.0% |
| Q4 FY2020 | Dec 31, 2020 | $25.21M | +131.7% |
| Q3 FY2020 | Sep 30, 2020 | $9.59M | -11.4% |
| Q2 FY2020 | Jun 30, 2020 | $10.01M | -11.4% |
| Q1 FY2020 | Mar 31, 2020 | $10.01M | -17.1% |
| Q4 FY2019 | Dec 31, 2019 | $10.88M | -12.8% |
| Q3 FY2019 | Sep 30, 2019 | $10.82M | -19.6% |
| Q2 FY2019 | Jun 30, 2019 | $11.31M | -21.7% |
| Q1 FY2019 | Mar 31, 2019 | $12.08M | -6.3% |
| Q4 FY2018 | Dec 31, 2018 | $12.48M | +318.4% |
| Q3 FY2018 | Sep 30, 2018 | $13.46M | +16673.7% |
| Q2 FY2018 | Jun 30, 2018 | $14.44M | +880783.0% |
| Q1 FY2018 | Mar 31, 2018 | $12.89M | +444.9% |
| Q4 FY2017 | Dec 31, 2017 | $2.98M | +8366.1% |
| Q3 FY2017 | Sep 30, 2017 | $80.26K | +84.5% |
| Q1 FY2017 | Mar 31, 2017 | $1.64K | – |
| Q4 FY2016 | Dec 31, 2016 | $2.36M | – |
| Q3 FY2016 | Sep 30, 2016 | $35.23K | – |
| Q2 FY2016 | Jun 30, 2016 | $43.50K | – |
See a number that looks wrong?